文献速递生殖医学产科

达拉斯子宫移植研究:20例中11例活产

Twelve Live Births After Uterus Transplantation in the Dallas UtErus Transplant Study.
PubMed 文献 · Obstet Gynecol · 2021-01-01

该前瞻性研究报告2016至2019年在达拉斯贝勒大学医学中心接受子宫移植的20例受者中活产情况。14例移植技术成功者中11例至少一次活产,每次尝试移植活产率55%,技术成功移植活产率79%;孕产妇医学和产科并发症可发生但可按常规产科原则管理。

要点

  • 每次尝试移植活产率55%,技术成功移植活产率79%
  • 妊娠达20周者均获晚期活产,中位分娩孕周36 6/7周
  • 孕产妇并发症包括肌酐升高、妊娠期糖尿病、高血压和子痫前期

核心结论

  • 前3年项目每次尝试移植活产率55%,技术成功移植活产率79%。
  • 妊娠达20周者均获晚期活产。
  • 孕产妇医学和产科并发症可发生,但按常规产科原则可管理。

研究设计与样本

  • 前瞻性研究,报告2016至2019年在达拉斯贝勒大学医学中心接受子宫移植的20例受者。
  • 活产发生于2017年11月至2020年9月。
  • 主要指标为活产、孕产妇并发症及胎儿和新生儿结局。

主要发现

  • 6例移植失败(4例手术并发症,2例术后灌注不良)。
  • 14例技术成功移植中11例至少一次活产。
  • 妊娠期检出1次器官排斥,经类固醇治疗缓解。

关键数值与推荐

  • 每次尝试移植活产率55%,技术成功移植活产率79%。
  • 中位出生体重2,890 g(范围1,770-3,140 g,中位第68百分位)。
  • 5例受者出现孕产妇医学并发症(肌酐升高、妊娠期糖尿病、妊娠期高血压[n=2]、子痫前期)。
  • 5例受者因医学或产科并发症导致非计划早产(肌酐升高、子痫前期;早产临产[n=3])。
  • 中位分娩孕周36 6/7周(范围30 6/7-38周),所有新生儿5分钟Apgar评分≥8。

临床怎么用

  • 子宫移植后妊娠需按常规产科原则管理孕产妇医学和产科并发症。
  • 妊娠达20周者在本研究中均获晚期活产,可为此类妊娠的咨询提供参考。

局限性

  • 单中心、 experienced center 经验,样本量20例。
  • 原文未报告对照设计或长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe aggregated pregnancy outcomes after uterus transplantation from a single, experienced center. METHODS: This prospective study reports on live births among 20 women who received a uterus transplant from 2016 to 2019 at Baylor University Medical Center at Dallas. These live births occurred between November 2017 and September 2020. The main measures were live birth, maternal complications, and fetal and newborn outcomes. RESULTS: There were six graft failures (four surgical complications and two with poor perfusion postoperatively). Of the 14 technically successful transplants, at least one live birth occurred in 11 patients. Thus far, the live birth rate per attempted transplant is 55%, and the live-birth rate per technically successful transplant is 79%. Ten uteri were from nondirected living donors and one uterus was from a deceased donor. In vitro fertilization was performed to achieve pregnancy. Ten recipients delivered one neonate, and one recipient delivered two neonates. One organ rejection episode was detected during pregnancy and was resolved with steroids. The median birth weight was 2,890 g (range 1,770-3,140 g [median 68th percentile]). Maternal weight gain was higher than Institute of Medicine recommendations. Maternal medical complications were observed in five recipients (elevated creatinine level, gestational diabetes, gestational hypertension [n=2], and preeclampsia). In five recipients, maternal medical or obstetric complications led to an unplanned preterm delivery (elevated creatinine level, preeclampsia; preterm labor [n=3]). The median gestational age at delivery was 36 6/7 weeks (range 30 6/7-38 weeks). All neonates were liveborn, with Apgar scores of 8 or higher at 5 minutes. CONCLUSION: Over the first 3 years, our program experienced a live-birth rate per attempted transplant of 55% and a live-birth rate per technically successful transplant of 79%. In our experience, uterus transplantation resulted in a third-trimester live birth in all cases in which pregnancies reached 20 weeks of gestation. Maternal medical and obstetric complications can occur; however, these were manageable by applying principles of generally accepted obstetric practice. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02656550.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Johannesson L, Testa G, Putman JM, et al. Twelve Live Births After Uterus Transplantation in the Dallas UtErus Transplant Study. Obstet Gynecol. 2021. PMID: 33416285. doi:10.1097/AOG.0000000000004244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。